# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001599298-24-000036
Filing Date
2024-03-05
Accepted
2024-03-05 16:05:09
Documents
18
Period of Report
2024-03-05
Items
Item 8.01: Other Events

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | smmt-20240305.htm iXBRL | 8-K | 28845
2 | EX-99.1 | a2024_prx0305xbarclayste.htm | EX-99.1 | 8352
7 |  | a2024_prx0305xbarclayste001.jpg | GRAPHIC | 257367
8 |  | a2024_prx0305xbarclayste002.jpg | GRAPHIC | 253140
| Complete submission text file | 0001599298-24-000036.txt |  | 900555

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | smmt-20240305.xsd | EX-101.SCH | 2161
4 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | smmt-20240305_def.xml | EX-101.DEF | 14787
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | smmt-20240305_lab.xml | EX-101.LAB | 28738
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | smmt-20240305_pre.xml | EX-101.PRE | 15429
19 | EXTRACTED XBRL INSTANCE DOCUMENT | smmt-20240305_htm.xml | XML | 2735

Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 650-460-8308
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36866 | Film No.: 24720236
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)